研究设计与统计

订阅

MedSci主页 / 所有栏目 / 研究设计与统计

除了associated with，还有哪些其他更弱的表示暴露因子和结局的表达方法？

2021-07-23 MedSci原创 MedSci原创

药物流行病学
关注

除了associated with，还有哪些其他更弱的表示暴露因子和结局的表达方法？

《梅斯直播课：药物流行病学——打开药物疗效和应用安全的钥匙 》

回答问题9：除了associated with，还有哪些其他更弱的表示暴露因子和结局的表达方法？

 

欢迎点赞、评论、分享

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1995714, encodeId=d27f1995e1454, content=<a href='/topic/show?id=eea918e1288' target=_blank style='color:#2F92EE;'>#With#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18712, encryptionId=eea918e1288, topicName=With)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Thu Apr 07 03:46:38 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1702971, encodeId=0f5a1e02971e0, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17254, encryptionId=72351e25437, topicName=TED)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76e230462388, createdName=aliceclz, createdTime=Fri Dec 10 05:46:38 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002073, encodeId=97bb10020e386, content=原来还有其他更弱的表示暴露因子和结局的表达方式, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61465555575, createdName=87890, createdTime=Fri Jul 23 18:46:43 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2022-04-07 cathymary

    #With#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1995714, encodeId=d27f1995e1454, content=<a href='/topic/show?id=eea918e1288' target=_blank style='color:#2F92EE;'>#With#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18712, encryptionId=eea918e1288, topicName=With)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Thu Apr 07 03:46:38 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1702971, encodeId=0f5a1e02971e0, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17254, encryptionId=72351e25437, topicName=TED)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76e230462388, createdName=aliceclz, createdTime=Fri Dec 10 05:46:38 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002073, encodeId=97bb10020e386, content=原来还有其他更弱的表示暴露因子和结局的表达方式, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61465555575, createdName=87890, createdTime=Fri Jul 23 18:46:43 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-12-10 aliceclz

    #TED#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1995714, encodeId=d27f1995e1454, content=<a href='/topic/show?id=eea918e1288' target=_blank style='color:#2F92EE;'>#With#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18712, encryptionId=eea918e1288, topicName=With)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Thu Apr 07 03:46:38 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1702971, encodeId=0f5a1e02971e0, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17254, encryptionId=72351e25437, topicName=TED)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76e230462388, createdName=aliceclz, createdTime=Fri Dec 10 05:46:38 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002073, encodeId=97bb10020e386, content=原来还有其他更弱的表示暴露因子和结局的表达方式, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61465555575, createdName=87890, createdTime=Fri Jul 23 18:46:43 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-07-23 87890

    原来还有其他更弱的表示暴露因子和结局的表达方式

    0

相关资讯

目前国际上有什么前沿的药物流行病学方向？

目前国际上有什么前沿的药物流行病学方向可以分享一下吗？-第六个

处理定量药物暴露的原则

处理定量药物暴露的原则-第七个问题

实验流行病学与队列研究的异同

实验流行病学与队列研究的异同-第三个问题

推荐适合小白入门的药物流行病学书籍？

有什么推荐的药物流行病学书籍吗？适合小白入门的这种

药物警戒与药物流行病学是什么样的关系？

药物警戒与药物流行病学是什么样的关系？-第五个问题.v

怎样获取数据库？

怎样获取数据库？